Popular heartburn medications such as Prilosec, Prevacid and Nexium could lead to an increased risk of chronic kidney disease. Read more
A Massachusetts federal judge has given tentative approval to a $24 million settlement between Teva Pharmaceutical Industries Ltd. and class action Plaintiffs in a pay-for-delay case over ge... Read more
The First Circuit Court of Appeals has upheld the certification of a class of indirect purchasers of Nexium in pay-for-delay litigation over the heartburn drug. The court ruled that the pres... Read more
The U.S. Food and Drug Administration (FDA) will require stronger warnings regarding risks associated with Nexium, Prilosec and other popular heartburn drugs. The FDA concluded that doctors... Read more
AstraZeneca, facing declining revenues last year, sold the marketing rights to its over-the-counter (OTC) version of Nexium to Pfizer Inc. for $250 million. AstraZeneca will be in line for m... Read more
The Food and Drug Administration warned consumers last month that certain stomach acid drugs may increase the risk of a serious intestinal bacteria infection. The drugs, including Nexium, Pr... Read more
The FDA has warned that taking certain drugs to treat symptoms of heartburn, acid reflux or ulcers may increase the risk of hip, wrist and spine fractures. The drugs belong to a class of med... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.